Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (41)

2024

  1. Clinical Perspectives, Eligibility, and Success Criteria for Bariatric/Metabolic Surgery

    Advances in experimental medicine and biology, Vol. 1460, pp. 677-695

2022

  1. High plasma and lingual uroguanylin as potential contributors to changes in food preference after sleeve gastrectomy

    Metabolism: Clinical and Experimental, Vol. 128

  2. Increased Levels of Interleukin-36 in Obesity and Type 2 Diabetes Fuel Adipose Tissue Inflammation by Inducing Its Own Expression and Release by Adipocytes and Macrophages

    Frontiers in Immunology, Vol. 13

  3. Serum Levels of IL-1 RA Increase with Obesity and Type 2 Diabetes in Relation to Adipose Tissue Dysfunction and are Reduced After Bariatric Surgery in Parallel to Adiposity

    Journal of Inflammation Research, Vol. 15, pp. 1331-1345

2021

  1. Decreased levels of microfibril‐associated glycoprotein (Magp)‐1 in patients with colon cancer and obesity are associated with changes in extracellular matrix remodelling

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  2. Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

  3. The differential expression of the inflammasomes in adipose tissue and colon influences the development of colon cancer in a context of obesity by regulating intestinal inflammation

    Journal of Inflammation Research, Vol. 14, pp. 6431-6446

2020

  1. FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes

    Metabolism: Clinical and Experimental, Vol. 108

  2. Impact of Routine and Long-Term Follow-Up on Weight Loss after Bariatric Surgery

    Obesity Surgery, Vol. 30, Núm. 11, pp. 4293-4299

  3. Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats

    International Journal of Obesity, Vol. 44, Núm. 2, pp. 475-487

2019

  1. GLP-1 limits adipocyte inflammation and its low circulating pre-operative concentrations predict worse type 2 diabetes remission after bariatric surgery in obese patients

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  2. Increase of the adiponectin/leptin ratio in patients with obesity and type 2 diabetes after roux-en-y gastric bypass

    Nutrients, Vol. 11, Núm. 9

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

  2. Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress

    Metabolism: Clinical and Experimental, Vol. 87, pp. 123-135

2017

  1. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

  2. Eligibility and success criteria for bariatric/metabolic surgery

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 529-543

  3. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss

    Clinical Nutrition, Vol. 36, Núm. 3, pp. 861-868

  4. Gastric Plication Improves Glycemia Partly by Restoring the Altered Expression of Aquaglyceroporins in Adipose Tissue and the Liver in Obese Rats

    Obesity Surgery, Vol. 27, Núm. 7, pp. 1763-1774

  5. IL-32α-induced inflammation constitutes a link between obesity and colon cancer

    OncoImmunology, Vol. 6, Núm. 7

  6. Role of aquaporin-7 in ghrelin-and GLP-1-induced improvement of pancreatic β-cell function after sleeve gastrectomy in obese rats

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1394-1402